Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.Diabetes, Obesity & Metabolism|May 22, 2020
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialClare Arnott, Yuli Huang, Brendon L Neuen, et al.Investigational New Drugs|October 28, 2003
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancerGlenn Liu, Kurt Oettel, Howard Bailey, et al.JACC. Heart Failure|April 29, 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE TrialsMilton Packer, John J V McMurray, Henry Krum, et al.BMJ Open|December 21, 2019
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF)Nobuhiro Ikemura, John A Spertus, Takehiro Kimura, et al.Cardiovascular Diabetology|July 19, 2022
Multi-dimensional characterization of prediabetes in the Project Baseline Health StudyRanee Chatterjee, Lydia Coulter Kwee, Neha Pagidipati, et al.The New England Journal of Medicine|May 21, 2004
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureMichael R Bristow, Leslie A Saxon, John Boehmer, et al.Journal of the American Heart Association|September 14, 2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) TrialJennifer A Rymer, Hillary Mulder, Kim G Smolderen, et al.Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.JAMA|February 10, 2011
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgeryMichael J Domanski, Kenneth Mahaffey, Vic Hasselblad, et al.Pageof 7